{"success":true,"data":{"pressRelease":{"id":"73265","rtpr_id":"nBwbwk9Bma","ticker":"EUFI","exchange":"Euronext Paris","all_tickers":["EUFI"],"title":"Eurofins Scientific: Director/PDMR Shareholding","author":"Business Wire","published_at":"2026-06-25T12:46:00.136Z","article_body":"Eurofins Scientific: Director/PDMR Shareholding\n\nEurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various\nnotifications of dealing from Persons Discharging Managerial Responsibilities\n(“PDMR”). The notification of Dealing Form for each PDMR can be found\nbelow.\n\nThis notification is made in accordance with the European Market Abuse\nRegulation.\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 62.721400                                                                                         2,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          2,000                                                                             \n     — Price                                                      EUR 125,442.80                                                                    \n e)  Date of the transaction                                      2026-06-22                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 64.845100                                                                                         2,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          2,000                                                                             \n     — Price                                                      EUR 129,690.20                                                                    \n e)  Date of the transaction                                      2026-06-23                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 66.576600                                                                                         1,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          1,000                                                                             \n     — Price                                                      EUR 66,576.60                                                                     \n e)  Date of the transaction                                      2026-06-24                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n\nAbout Eurofins – the global leader in bio-analysis\n\nEurofins is Testing for Life. With over 65,000 staff across a network of more\nthan 950 laboratories in over 1,000 companies in 59 countries, Eurofins offers\na portfolio of over 200,000 analytical methods.\n\nEurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260625549084/en/\n(https://www.businesswire.com/news/home/20260625549084/en/)\n\nFor more information, please visit www.eurofins.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.eurofins.com%2F&esheet=54560287&newsitemid=20260625549084&lan=en-US&anchor=www.eurofins.com&index=1&md5=b061add9fbe662125b281bfe14643bc2)\nor contact:\n\nInvestor Relations\n\nEurofins Scientific SE\n\nPhone: +32 2 766 1620\n\nE-mail: ir@sc.eurofinseu.com (mailto:ir@sc.eurofinseu.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBwbwk9Bma","title":"Eurofins Scientific: Director/PDMR Shareholding","author":"Business Wire","ticker":"EUFI","created":"2026-06-25T12:46:00.136Z","tickers":["EUFI"],"exchange":"Euronext Paris","article_body":"Eurofins Scientific: Director/PDMR Shareholding\n\nEurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various\nnotifications of dealing from Persons Discharging Managerial Responsibilities\n(“PDMR”). The notification of Dealing Form for each PDMR can be found\nbelow.\n\nThis notification is made in accordance with the European Market Abuse\nRegulation.\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 62.721400                                                                                         2,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          2,000                                                                             \n     — Price                                                      EUR 125,442.80                                                                    \n e)  Date of the transaction                                      2026-06-22                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 64.845100                                                                                         2,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          2,000                                                                             \n     — Price                                                      EUR 129,690.20                                                                    \n e)  Date of the transaction                                      2026-06-23                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING                                                                          \n MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM                                                                               \n                                                                                                                                                    \n 1.  Details of the person discharging managerial responsibilities/person closely                                                                   \n     associated                                                                                                                                     \n a)  Name                                                         Analytical Bioventures S.C.A (RCS B89265)                                         \n                                                                  \n23, Val Fleuri, L-1526 Luxembourg                                                \n                                                                                                                                                    \n 2.  Reason for the notification                                                                                                                    \n a)  Position / status                                            Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific      \n                                                                  S.E., CEO Dr. Gilles Martin                                                       \n b)  Initial notification / amendment                             Initial                                                                           \n                                                                                                                                                    \n 3.  Details of the issuer, emission allowance market participant, auction                                                                          \n     platform, auctioneer or auction monitor                                                                                                        \n a)  Name                                                         Eurofins Scientific S.E.                                                          \n b)  LEI                                                          529900JEHFM47DYY3S57                                                              \n                                                                                                                                                    \n 4.  Details of the transaction(s) section to be repeated for (i) each type of                                                                      \n     instrument; (ii) each type of transaction; (iii) each date; and (iv) each                                                                      \n     place where transactions have been conducted                                                                                                   \n a)  Description of the financial instrument, type of instrument  Share                                                                             \n     Identification code                                          ISIN: FR0014000MR3                                                                \n b)  Nature of the transaction                                    Acquisition of shares                                                             \n                                                                                                                                                    \n c)  Price(s) and volume(s)                                       Price(s)                                 Volume(s)                                \n     EUR 66.576600                                                                                         1,000                                    \n d)  Aggregated information                                                                                                                         \n     — Aggregated volume                                          1,000                                                                             \n     — Price                                                      EUR 66,576.60                                                                     \n e)  Date of the transaction                                      2026-06-24                                                                        \n f)  Place of the transaction                                     XPAR                                                                              \n\n\nAbout Eurofins – the global leader in bio-analysis\n\nEurofins is Testing for Life. With over 65,000 staff across a network of more\nthan 950 laboratories in over 1,000 companies in 59 countries, Eurofins offers\na portfolio of over 200,000 analytical methods.\n\nEurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260625549084/en/\n(https://www.businesswire.com/news/home/20260625549084/en/)\n\nFor more information, please visit www.eurofins.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.eurofins.com%2F&esheet=54560287&newsitemid=20260625549084&lan=en-US&anchor=www.eurofins.com&index=1&md5=b061add9fbe662125b281bfe14643bc2)\nor contact:\n\nInvestor Relations\n\nEurofins Scientific SE\n\nPhone: +32 2 766 1620\n\nE-mail: ir@sc.eurofinseu.com (mailto:ir@sc.eurofinseu.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-06-25T12:46:00.1791385Z","server_sent_at_ms":1782391560179},"received_at":"2026-06-25T12:46:00.329Z","source_url":"https://www.businesswire.com/news/home/20260625549084/en/"},"analysis":{"id":"62631","press_release_id":"73265","analysis_json":{"industry":{"label":"Life Sciences Tools & Services","sector":"Health Care"},"redFlags":[],"eventType":"insider_transaction","narrative":"Analytical Bioventures S.C.A., a company controlled by CEO Dr. Gilles Martin, acquired 5,000 shares of Eurofins Scientific SE across three transactions between June 22 and June 24.\n\nThe purchases were executed at prices ranging from EUR 62.72 to EUR 66.58 per share, for an aggregated total value of approximately EUR 321,700.\n\nThe notification was made in accordance with the European Market Abuse Regulation.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Small insider buy from CEO's vehicle."},"keyFigures":{"customDimensions":{"shares_acquired":5000,"total_value_eur":"EUR 321,709.60","transaction_1_volume":2000,"transaction_2_volume":2000,"transaction_3_volume":1000}},"quotedText":"","namedEntities":{"people":[{"name":"Dr. Gilles Martin","role":"CEO"}],"products":[],"companies":[{"name":"Eurofins Scientific SE","ticker":"EUFI"},{"name":"Analytical Bioventures S.C.A","relationship":"PDMR (Controlled by CEO)"}],"dollarAmounts":[{"amount":"EUR 125,442.80","context":"Acquisition of 2,000 shares on 2026-06-22"},{"amount":"EUR 129,690.20","context":"Acquisition of 2,000 shares on 2026-06-23"},{"amount":"EUR 66,576.60","context":"Acquisition of 1,000 shares on 2026-06-24"}]},"materialImpact":{"score":2,"reasoning":"Insider buying by a CEO-controlled entity totaling ~EUR 322k. While generally a positive signal, the monetary value is routine and immaterial relative to the company's market cap."},"tickerRelevance":{"others":[{"ticker":"ERF","relevance":"listing_ticker"}],"primary":"EUFI"},"globalImportance":10,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large_cap","eventGravity":"routine_insider_buy"}},"event_type":"insider_transaction","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Analytical Bioventures S.C.A., a company controlled by CEO Dr. Gilles Martin, acquired 5,000 shares of Eurofins Scientific SE across three transactions between June 22 and June 24.\n\nThe purchases were executed at prices ranging from EUR 62.72 to EUR 66.58 per share, for an aggregated total value of approximately EUR 321,700.\n\nThe notification was made in accordance with the European Market Abuse Regulation.","key_figures":{"customDimensions":{"shares_acquired":5000,"total_value_eur":"EUR 321,709.60","transaction_1_volume":2000,"transaction_2_volume":2000,"transaction_3_volume":1000}},"named_entities":{"people":[{"name":"Dr. Gilles Martin","role":"CEO"}],"products":[],"companies":[{"name":"Eurofins Scientific SE","ticker":"EUFI"},{"name":"Analytical Bioventures S.C.A","relationship":"PDMR (Controlled by CEO)"}],"dollarAmounts":[{"amount":"EUR 125,442.80","context":"Acquisition of 2,000 shares on 2026-06-22"},{"amount":"EUR 129,690.20","context":"Acquisition of 2,000 shares on 2026-06-23"},{"amount":"EUR 66,576.60","context":"Acquisition of 1,000 shares on 2026-06-24"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-25T13:21:04.915Z","global_importance":10,"audience_relevance":10,"importance_components":{"tickerTier":"large_cap","eventGravity":"routine_insider_buy"}},"durationMs":128634,"modelName":"george-droid-qwen-72b"}}